TrialGeroScience2023

The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial.

Lin Yi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.